NYSE$NEUE
NeueHealth Inc · Q4 2022 earnings
Q4 2022 earnings · · Investor relations
Briefing
Reported fourth quarter and full year 2022 results, focusing on continuing business anchored by Consumer Care and Bright HealthCare segments, and successfully exited ACA insurance business.
Bright Health Group reported Q4 2022 results with revenue of $551.4 million and a net loss of $188.2 million. The company is focusing on its Consumer Care and Bright HealthCare segments after exiting its ACA insurance business.
- Q4 2022 revenue from continuing business was $551.4 million.
- Q4 2022 net loss from continuing business was $188.2 million.
- Q4 2022 adjusted EBITDA loss from continuing business was $108.5 million.
- The company is maintaining its expectation for 2023 adjusted EBITDA profitability.
Headline financials
Revenue & EPS history
NeueHealth · Revenue · Quarterly
$551M
Forward guidance
Bright Health Group's 2023 outlook remains consistent with the update provided in January 2023, but the company's expectation for Revenue is now lower due to our finalized accounting treatment on certain value-based care contracts. Operating Cost expectations are unchanged, but is now forecast to be a higher percent of Revenue.
Tailwinds
- Enterprise Revenue is expected to be between $2.9 billion and $3.1 billion.
- Bright HealthCare Revenue is expected to be greater than $1.8 billion.
- Consumer Care Revenue is expected to be between $1.1 billion and $1.3 billion.
- Enterprise Adjusted Operating Cost Ratio is expected to be between 13% and 14%.
- Bright Health Group expects to be Adjusted EBITDA profitable in 2023
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports · overlaid with Q4 2022
-2.0%
Avg return
Earnings day
-6.9%
Avg return
5 days after
-17.7%
Avg return
30 days after
45%
10 / 22 earnings
Positive
+46.5%
Q1 2023
Best reaction
-43.1%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2025 | +0.0% | -2.2% | -2.1% | |
| Q1 2025 | -2.2% | -0.4% | -1.5% | |
| Q4 2024 | +8.9% | +30.9% | +29.9% | |
| Q3 2024 | +2.2% | +2.5% | +7.8% | |
| Q2 2024 | -3.6% | +2.3% | -4.4% | |
| Q1 2024 | -4.0% | -3.7% | -14.3% | |
| Q4 2023 | +7.6% | -6.0% | -27.7% | |
| Q3 2023 | -1.5% | -10.2% | -15.5% | |
| Q2 2023 | -21.8% | -27.8% | -61.3% | |
| Q1 2023 | +46.5% | +7.2% | -14.1% | |
| Q4 2022 | -43.1% | -48.8% | -77.2% | |
| Q3 2022 | +4.3% | -3.7% | -15.3% | |
| Q2 2022 | -9.3% | +2.1% | -15.1% | |
| Q1 2022 | +35.7% | +26.0% | -0.6% | |
| Q4 2019 | -2.6% | -1.3% | -16.4% | |
| Q4 2021 | -29.5% | -42.9% | -35.6% | |
| Q3 2020 | +1.3% | -13.1% | -15.4% | |
| Q3 2021 | -35.1% | -34.4% | -40.5% | |
| Q2 2020 | +5.1% | — | — | |
| Q1 2021 | +5.1% | — | — | |
| Q4 2020 | +5.1% | — | — | |
| Q2 2021 | -13.6% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro